logo

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

  5 days ago   
post image
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
Ticker Sentiment Impact
PFE
Neutral
31 %